๐ฅ๐๐ค๐ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ / ๐ฆ๐ฒ๐ป๐ถ๐ผ๐ฟ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ ๐๐ ๐๐
๐ฅ๐๐ค๐ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ / ๐ฆ๐ฒ๐ป๐ถ๐ผ๐ฟ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ ๐๐ ๐๐
Key Skills
Job Description
Company Description MicroPort NeuroScientific (MPNS), a subsidiary of MicroPort Scientific Corporation, focuses on next-generation neuro-interventional technologies that transform the treatment of complex neurovascular diseases. Founded in 2012 and listed on the Hong Kong Stock Exchange in 2022, MPNS develops integrated technology platforms for hemorrhagic stroke, intracranial atherosclerotic stenosis, and acute ischemic stroke. Headquartered in Shanghai, its solutions are used in more than 3,700 hospitals and have supported treatment for over 650,000 patients worldwide. With a growing international presence across North America, Latin America, EMEA, and Asia-Pacific, MPNS collaborates closely with physicians and research institutions to turn clinical insights into scalable innovations. The company is committed to being a trusted global partner in neurovascular innovation and improving patient outcomes worldwide. Key Responsibilities ยท Prepare, compile, review and maintain EU MDR technical documentation and regulatory submission dossiers for medical devices. ยท Support new product registrations, renewals, regulatory changes and lifecycle management activities across Europe and other EMEA markets, including Russia, Kazakhstan and Egypt. ยท Support interactions and submissions with EU Notified Bodies, Competent Authorities and other regulatory authorities within the EMEA region. ยท Assess the regulatory impact of product, design, manufacturing, supplier and labeling changes and coordinate required regulatory actions. ยท Monitor relevant regulatory requirements, standards and guidance and translate regulatory changes into actionable requirements. ยท Work closely with R&D, Clinical, Quality and other cross-functional teams to ensure timely delivery of regulatory projects. ยท Provide regulatory documentation and technical support for reimbursement, tender, market access and other local regulatory-related requirements in EMEA markets. ยท Support distributors and local partners with regulatory documentation required for product registration and market access. Quality Assurance ยท Maintain and support the ISO 13485 Quality Management System and ensure continued compliance with applicable requirements. ยท Maintain QMS procedures, records and quality documentation and support alignment with the corporate Quality Management System. ยท Support internal and external audits and coordinate follow-up actions and CAPA where required. ยท Support key quality processes including document control, training, change control, CAPA, complaint handling and supplier/distributor quality management. ยท Support post-market quality and regulatory activities, including complaints, vigilance reporting, field safety corrective actions and regulatory reporting, as applicable. ยท Support management review, quality objectives, quality metrics and continuous improvement activities. HR Contact Person๏ผEven Chen; Email Address: [email protected]
Core Responsibilities
Prepare and maintain medical-device regulatory documentation, submissions, registrations, and lifecycle activities across Europe and other EMEA markets, while supporting regulatory authorities, notified bodies, distributors, and market-access needs. Maintain the ISO 13485 quality management system and support audits, CAPA, quality processes, post-market activities, and continuous improvement.
Requirements
The posting does not specify formal education, years of experience, or other candidate qualifications. The roleโs responsibilities indicate a need for expertise in medical-device regulatory affairs and quality assurance, including EU MDR, ISO 13485, regulatory submissions, and QMS processes.
About MicroPort NeuroScientific
Industry: Medical Equipment Manufacturing
Company size: 501-1,000 employees
MicroPort NeuroScientific (MPNS), formerly known as MicroPort NeuroTech, is a subsidiary of MicroPort Scientific Corporation focused on advancing next-generation neuro-interventional technologies. Founded in 2012 and listed on the Hong Kong Stock Exchange in 2022 (02172.HK), MPNS is committed to transforming the treatment of complex neurovascular diseases through continuous innovation and global clinical collaboration. Guided by MicroPortโs mission to break technological and accessibility barriers, MPNS develops integrated neurovascular technology platforms designed to improve patient outcomes and expand treatment accessibility worldwide. The company delivers comprehensive device solutions across three major neurovascular disease areas: โข Hemorrhagic Stroke โข Intracranial Atherosclerotic Stenosis (ICAS) โข Acute Ischemic Stroke (AIS) Headquartered in Shanghai, MPNS holds a leading position in Chinaโs neuro-interventional market. Its technologies have been adopted in more than 3,700 hospitals and have supported treatment for over 650,000 patients globally. With a rapidly expanding international presence across North America, Latin America, EMEA, and Asia-Pacific, MPNS employs more than 500 professionals worldwide. The company collaborates closely with physicians, research institutions, and global clinical partners to translate frontline clinical insights into scalable technology platforms that advance the future of neurovascular care. MPNS is committed to becoming a trusted global partner in neurovascular innovation and improving patient outcomes worldwide. To know more about us, please click: https://www.microportneuro.com/